# Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate

> **NCT05362032** · NA · SUSPENDED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 45 (estimated)

## Conditions studied

- Prostate Carcinoma

## Interventions

- **DEVICE:** Biopsy
- **PROCEDURE:** Endorectal Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT05362032
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-05-08
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-07-30
- **Target enrollment:** 45 (ESTIMATED)
- **Why stopped:** Study team paused enrollment
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05362032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05362032, "Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05362032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*